Your session is about to expire
← Back to Search
Fecal Microbiota Transplantation for Genitourinary Cancers
Study Summary
This trial studies how well fecal microbiota transplantation works in treating diarrhea or colitis caused by certain medications. Fecal microbiota transplantation may reduce the incidence of these conditions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many individuals have been recruited to participate in this investigation?
"Affirmative. The details on clinicaltrials.gov affirm that this study is actively looking for participants and began recruitment on February 1st 2021. At the moment, 40 volunteers are needed to be recruited from one medical centre before October 17th 2022."
Are there any unoccupied positions in this clinical investigation?
"The research team is currently looking for eligible participants. The initial posting of the trial was on February 1st, 2021 and it has been amended as recently as October 17th, 2022 according to clinicaltrials.gov."
What condition is typically remedied through loperamide, colonoscopy and FMT?
"Treatment (loperamide, colonoscopy, FMT) is typically used in order to manage inflammatory bowel diseases (IBD), looseness of the bowels and chronic functional diarrhea."
Does this medical experiment introduce any groundbreaking concepts?
"Currently, there are 9 ongoing clinical trials examining the efficacy of Treatment (loperamide, colonoscopy, FMT) in 63 cities and 19 countries. The first such study was conducted by Eli Lilly and Company back in 2014 with 198 participants taking part. Since then, an additional 39 studies have been launched."
Has the FDA sanctioned loperamide, colonoscopy, or FMT as a therapeutic measure?
"Our experts at Power have evaluated the safety of this treatment plan (loperamide, colonoscopy and FMT) to be a 1 as it is in its initial phase of testing. Efficacy data is still sparse while any evidence supporting safety has been limited."
What research has been conducted to assess the efficacy of loperamide, colonoscopy and FMT for treating patients?
"Currently, 9 experiments surrounding Treatment (loperamide, colonoscopy, FMT) are underway with 1 trial in Phase 3. Nagoya-shi, Aichi is the primary location of these Trails while 156 sites are participating in clinical trials related to Treatment (loperamide, colonoscopy, FMT)."
Share this study with friends
Copy Link
Messenger